However, current research has also revealed mechanisms not recognized in traditional medicine, such as modulation of gene expression, inhibition of specific signaling pathways (NF-κB, Nrf2), and targeted effects on metabolic disorders like type 2 diabetes and certain cancers. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.